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Mechanism of alkaloid cyclopeptide synthesis in the ergot 
fungus Claviceps purpurea 
Bernd Walzel, Brigitte Riederer and Ullrich Keller 
Background: Previous analyses of the biosynthesis of the alkaloid cyclopeptides 
from the ergot fungus Claviceps purpurea were hampered by a lack of suitable 
systems for study in vitro, and this led to conflicting results concerning the 
mechanism of alkaloid cyclopeptide formation. Recently, o-lysergyl peptide 
synthetase (LPS) of the ergot fungus Claviceps purpurea, which assembles the 
non-cyclol precursors of the ergopeptines, has been partially purified and shown to 
consist of two polypeptide chains of 370 kDa (LPS 1) and 140 kDa (LPS 2); these 
contain all the sites necessary for the assembly of the D-lysergyl peptide backbone. 
The mechanism of D-lysergyl peptide synthesis remained unclear, however. 
Results: We have identified the obligatory peptidic intermediates in D-@Sergyl 
peptide synthesis and the sequential order of their formation. The two LPS 
subunits catalyze the formation of D-&X3rgyl mono-, di-, and tripeptides as 
enzyme-thioester intermediates, the formation of which appears to be 
irreversible. Peptide synthesis starts when D-@I?rgiC acid binds to the LPS 2 
subunit, which most probably occurs after the previous round of synthesis has 
been completed by the release of the end product from the LPS enzyme. 
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Conclusions: We have shown that the mechanism of o-lysergyl peptide 
synthesis is an ordered process of successive acyl transfers on a multienzyme 
complex. This knowledge opens the way for enzymatic and genetic investigations 
into the formation of novel alkaloid cyclopeptides. 
Introduction 
Ergot peptide alkaloids (ergopeptines) are predominantly 
formed by grass-parasitizing filamentous fungi, including 
the ergot fungus &viceps purpurea. This fungus is the 
causative agent of numerous epidemics of ergotism in 
humans reported from the middle ages until the 1920s [ 11. 
Peptide alkaloids all contain rAysergic acid attached in 
amide linkage to cyclol-structured tripeptides which differ 
from each other by various substitutions in the variable 
amino-acid positions as shown in Figure 1. The I,-lysergic 
acid moiety, a most potent pharmacophore, is essential for 
the pharmacological activities of alkaloid cyclopeptides. 
The various D-lysergic acid amides or peptides and their 
dihydro derivatives have uterotone, vasodilatory or vaso- 
constrictive actions. They induce hypothermia and emesis 
or control the secretion of the pituitary hormones [Z]. 
These effects are mainly due to their interaction with 
various receptor sites of the noradrenaline, serotonin or 
dopamine neurotransmitter families [3]. Variations in the 
peptide sidechains greatly affect the affinities of the alka- 
loid peptides for specific receptors. No other group of sub- 
stances exhibits such a wide spectrum of biological actions 
as the I,-lysergic acid peptides. 
Many research groups have studied the Zn aitro and in Gvo 
biosynthesis of alkaloid peptides with the aim of increasing 
the pharmacological uses of these compounds [4-71. These 
studies provide a clear picture of the enzyme-catalyzed 
steps in the formation of the ergoline ring of [>-lysergic 
acid from dimethylallyl pyrophosphate and tryptophan [8]. 
In contrast, the enzymatic basis for the assembly of the 
I,-lysergyl peptide backbone from l>-lysergic acid (or its pre- 
cursor) and the three amino acids of the tripeptide portion 
remained unclear. The various models for the assembly of 
ergopeptines, determined from cell-free and in V~UO data, 
differ from each other in whether n-lysergic acid or one of 
its precursors was thought to take part in the assembly 
process of Mysergyl peptides. The models also suggested 
an unusual direction of peptide-chain growth and it was 
unclear whether the precursor peptides remained enzyme- 
bound throughout the assembly of the I)-lysergyl peptide 
backbone [9-l 11. 
We have shown previously that a large multifunctional 
enzyme, Mysergyl peptide synthetase (LPS), from the 
ergot fungus C. purpzlreu synthesizes the non-cyclol 
D-lysergyl peptide lactams ([l&13]; Fig. 2) which have 
been suggested to be the penultimate precursors of the 
corresponding cyclol-structured ergopeptines [14]. The 
enzymatic formation of these compounds in vitro pro- 
vided the starting point for studying the enzymatic basis 
of alkaloid peptide synthesis in more detail than had been 
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Figure 1 
General structure of cyclol-type alkaloid peptides (ergopeptines). The 
ergotamine group contains: R, =-Me , R,= -Et, -benzyl, -isobutyl or 
-isopropyl; the ergoxine group contains: R, =-Et, R,= -Et, -benzyl, 
-isobutyl or -isopropyl; the ergotoxine group contains: R, =-isopropyl, 
R, = -Et, -benzyl, -isobutyl or -isopropyl side groups, 
possible before. Analysis of the purified enzyme revealed 
that it consists of two polypeptide chains, LPS 1 and 
LPS 2. LPS 1 (nl, = 370000) covalently binds the three 
amino acids of the peptide nucleus, and LPS 2 
(M, = 140000) covalently binds [j-lysergic acid. The 
binding reactions are ATP-dependent and the bonds are 
thioester linkages. LPS thus resembles the antibiotic 
peptide synthetases from bacteria and filamentous fungi 
[1.5,16]. Here, we show that I)-lyscrgyl peptide lactam is 
synthesized by LPS as a chain growing from its amino tcr- 
minus. [)-Lysergic acid is the starter unit, and covalently 
bound ~lyscrgyl mono-, di- and tripeptides are short- 
lived intermediates. Specific intermediates accumulated 
under conditions that did not allow completion of I)-lyser- 
gyl peptide lactam synthesis. suggesting that the)- bind to 
LPS in a predetermined, sequential manner. 
Results and discussion 
Substrate binding of D-lysergyl peptide synthetase 
LPS binds [,-lysergic acid and three amino acids (e.g. 
alanine, phenylalanine and proline for ergotamine) as 
thioesters in an ATP-dependent reaction. This resembles 
the nonribosomal protein thiol-template systems [ 171, and 
suggests the presence of four peptide-synthetase domains 
on the LPS multienzyme complex. Each of the domains 
would be responsible for the activation of adenylate and 
for the thioester formation of one of the components of 
I)-lysergyl peptide. Surprisingly, when we routinely tested 
thioester formation in our filter-binding assays, thioester 
formation was almost undetectable when purified LPS was 
incubated with all four substrates that are necessary for the 
synthesis of the end product. The individual substrates 
alone, however, bound the enzyme to saturation within 
6-10 min in a typical hyperbolic fashion (results not shown). 
In order to characterize the role of substrate binding in the 
mechanism of I)-lysergyl peptide formation, we tested the 
loading of the enzyme with “H-dihydrolysergic acid in the 
Figure 2 
General structure of non-cyclol structured alkaloid peptides. The 
substituents R, and R, are the same as for the ergopeptines (see Fig. 1). 
presence of 2 rnnl alanine, which is the amino acid that 
binds directly to I)-lysergic acid (see Fig. 1). In this reac- 
tion, achieving saturation required a longer incubation than 
the previous experiments (up to 20 min), and the total 
amount of ‘H-dihydrolysergic acid that bound to the 
enzyme increased 1.5fold. This indicated that the pres- 
ence of alanine affects dihydrolysergic acid binding. L\:hen 
2 rnnl alanine and 2 mM phenylalanine (the amino acid 
next to alanine in the peptide chain of ergotamine) w.ere 
added to the reaction, the maximal amount of bound .‘H- 
dihydrolysergic acid \vas reduced to the le\;el observed 
without added amino acid (data not shown). These results 
were difficult to understand and prompted us to investi- 
gate the events during thioester formation in more detail 
by directly analyzing the intermediates that wcrc bound 
to LPS. 
Isolation and characterization of intermediates of 
D-lysergyl peptide synthesis 
Enzyme-substrate complexes, prepared with “H-dihydro- 
lysergic acid in the presence or absence of nonlabelled 
alanine, phenylalanine or prolinc, m-ere treated with mild 
alkali to hydrolyze the thioestcr bonds. The released IOM 
molecular weight radioactive substances were extracted 
by solid-phase adsorption, followed by clution from the 
adsorbent with methanol as described in the nlaterials and 
methods section. 
Incubation of LPS with “H-dihydrolysergic acid alone 
yielded exclusively radioactive dihydrolysergic acid (I), 
as expected (Fig. 3; lane a, band I). Addition of I,-alaninc 
produced dihydrolyscrgic acid and a new compound 
(I;ig. 3; lane b, band II) with a slightly higher R+-value. 
Addition of alanine and phenylalanine produced three 
radioacti1.e compounds, one of which was a new com- 
pound (Fig. 3; lane c, band III). Incubation of LPS with 
“H-dihydrolysergic acid and phenylalanine without alanine 
resulted in dihydrolysergic acid only, without any addi- 
tional, new compounds (data not shown). This suggcstcd 
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Figure 3 
Formation of dihydrolysergyl peptide 
intermediates covalently bound to LPS. 
Incubation of LPS with 3H-dihydrolysergic 
acid in the presence of nonlabelled amino- 
acid substrates; each track represents a TLC 
separation in solvent system I of material 
released from the enzyme by alkaline 
treatment, as described in the Materials 
and methods section. The reaction mixtures 
for lanes a-e contained Mg ATP and 
3H-dihydrolysergic acid (band I). For lane b, 
alanine was added to the reaction mixture, 
giving band II, which contain dihydrolysergyl- 
alanine; for lanes c and e, alanine and 
phenylalanine were added and 
dihydrolysergyl-alanyl-phenylalanine was 
produced (band Ill); for lane d, alanine, 
phenylalanine and proline were added and 
small amounts of dihydrolysergyl-alanine and 
dihydrolysergyl-alanyl-phenylalanine were 
produced (bands II and Ill, respectively); 
lanes f and g are controls - reactions with 
nonradioactive dihydrolysergic acid, Mg ATP 
and one labelled amino acid - lane f, 
3H-alanine and phenylalanine; lane g, alanine 
and 14C-phenylalanine (separations e, f, g 
were performed on a different TLC plate). The 
structures of the compounds in bands I-III are 
shown. 
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that dihydrolysergic acid and phenylalanine did not react 
with each other. 
The new compounds (bands II and III) were isolated and 
subjected to alkaline hydrolysis. Both cases yielded 
radioactive dihydrolysergic acid. When “H-alanine, non- 
radioactive phenylalanine and dihydrolysergic acid were 
incubated with LPS, bands II and III were radiolabelled, 
indicating that both compounds contained alanine (Fig. 3; 
lane f). In the same experiment, only band III was 
labelled with labelled phenylalanine, indicating that this 
was the only reaction intermediate containing phenylala- 
nine (Fig. 3; lane g:). These results strongly suggested that 
band II contained dihydrolysergyl-alanine and band III 
dihydrolysergyl-alanyl-phenylalanine. This was confirmed 
by chromatographic comparison with chemically synthe- 
sized dihydrolysergyl-alanine and dihydrolysergyl-alanyl- 
phenylalanine (data not shown). 
formed were identified as dihydrolysergyl-aminobutyrate 
(IV) and dihydrolysergyl-valine (V) by chromatographic 
comparison with chemically synthesized authentic dihy- 
drolysergyl-aminobutyrate and dihydrolysergyl-valine (data 
not shown). Their formation in a&o indicates that the 
ergoxines and ergotoxines are synthesized by the same 
mechanism as the ergotamines. 
These data strongly suggest that LPS initiates alkaloid 
peptide synthesis by the condensation of covalently bound 
I,-dihydrolysergic acid (or D-lysergic acid in natural biosyn- 
thesis) with covalently bound alanine (or aminobutyric acid 
or valine). Further condensation with covalently bound 
phenylalanine, as shown in Figure 3, would be the first 
elongation step. Peptide chain growth therefore proceeds 
as usual from the amino terminus (n-lysergic acid) to the 
carboxyl terminus. 
Proline incorporation and the cyclization step 
We have shown previously that LPS also synthesizes To characterize the missing intermediate between dihy- 
n-lysergyl peptide lactams of the ergoxine and ergotoxine drolysergyl dipeptide and the final product, dihydrolysergyl- 
types. Instead of alanine, these contain Z-amino butyric alanyl-phenylalanyl-proline-lactam (Fig. Z), LPS was 
acid or valine respectively, linked to u-lysergic acid. Figure incubated with “H-dihydrolysergic acid, alanine, phenylala- 
4 shows the formation of covalently bound products when nine and proline. [Jnder these conditions, much smaller 
LPS was incubated with “H-dihydrolysergic acid in the amounts of the enzyme-bound intermediates were recov- 
presence of aminobutyric acid or valine. The compounds ered than in previous experiments (Fig. 3; lane d). Parallel 
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Figure 4 
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Formation of dihydrolysergyl intermediates of the ergotamine, ergoxine 
and ergotoxine group covalently bound to LPS. Each track represents 
a TLC separation in solvent system I of material released from the 
enzyme by alkaline treatment as described in the Materials and 
methods section. The reaction mixtures for lanes a-d contained 
Mg ATP and sH-dihydrolysergic acid; lane b, the reaction mixture also 
contained alanine (band II contains dihydrolysergyl-alanine); lane c, 
aminobutyric acid was added (band IV contains dihydrolysergyl- 
aminobutyric acid); lane d, valine was added (band V contains 
dihydrolysergyl-valine). The structures of the compounds in bands IV 
and V are shown. 
experiments showed, however, that free dihydrolysergyl 
peptide lactam had been formed in appreciable levels (data 
not shown). This indicated that, in conditions favouring the 
formation of the end product, the various steps of residue 
activation, condensation and final cyclization are efficiently 
coordinated, precluding the accumulation of substrates or 
intermediates. Turnover of D-lysergyl peptide lactam forma- 
tion catalyzed by D-lySergyl peptide synthetase was esti- 
mated from several independent experiments to be of the 
order of 1 min.‘. This seems consistent with the 6-8 min 
required for the enzyme to become: completely charged with 
either dihydrolysergic acid or any of the three amino acids. 
We attempted to isolate enzyme-bound I>-lysergyl-alanyl- 
phenylalanyl-praline. Thioesterase activities have been 
implicated previously in the release or cyclization of prod- 
ucts in fatty acid, polyketide and cyclic peptide synthesis 
[18-221. In fatty acid synthase (FAS), thioesterase is an 
integral part of the multienzyme [23]. The thioesterase 
activity of FAS can be inhibited by phenylmethylsulfonyl 
fluoride (PMSF) or related compounds, leading to the 
accumulation of long chain fatty acyl residues bound to 
the enzyme [23]. PMSF did not affect the capability of 
LPS to synthesize I>-lysergyl peptide lactam, however. 
Attempts to incorporate the proline analogues azetidine-Z- 
carboxylic acid, pipecolic acid (homoproline) or sarcosine, 
which were not expected to cyclize readily, instead of 
proline, did not result in the expected I,PS-bound 
intermediates. This indicated that the proline-activation 
domain of LPS 1 was specific for proline in our Zn a& 
reactions. This is consistent with previous reports in which 
whole ceils of C. pzlrpzlrea did not incorporate proline 
analogues into ergotamine [7]. Thus, no modifying agent 
or substrate was available to block the last step of the 
LPS reactions. 
Storage of enzyme for several weeks at < -20°C in a buffer 
lacking dithioerythritol (DTE) and containing SO % gly- 
cerol produced a preparation that had lost the ability to 
synthesize I,-lysergyl peptide lactam but was still able to 
form thioesters with dihydrolysergic acid, alanine, pheny- 
lalanine and proline. We therefore considered the possibil- 
ity that a block in the final synthetic step of cyclization 
and product release prevented total synthesis and did 
not affect the activation reactions of the individual sub- 
strates. A partially inactivated enzyme preparation was 
therefore incubated with “H-dihydrolysergic acid, alanine, 
phenylalanine or proline in the same combinations as 
used for Figure 3. Enzyme-bound dihydrolysergyl mono- 
and dipeptides were synthesized as expected 
(Fig. 5; lanes b,c; bands 11,111). The addition of all three 
amino acids, including proline, produced a new radioac- 
tive compound (Fig. 5; lane d, band VI). Control experi- 
ments using 14C-proline instead of “H-dihydrolysergic acid 
revealed exclusive labelling of this band (data not shown), 
providing strong evidence that this compound was dihy- 
drolysergyl-alanyl-phenylalanyl-proline. The synthesis of 
alkaloid cyclopeptides therefore proceeds via the lysergyl 
mono-, di- and tripeptides. It must be noted, however, 
that freshly prepared enzyme, or enzyme stored in DTE- 
containing buffer, synthesized n-lysergyl peptide lactam 
but never synthesized any detectable amount of the 
D-lysergyl tripeptide intermediate (Fig. 3; lane d). 
D-Lysergic acid is the primer for LPS-catalyzed peptide 
synthesis 
To confirm that D-lysergic acid is the starter unit in the 
reaction, and resolve the controversy over the direction of 
peptide formation [lo], we attempted to demonstrate the 
Figure 5 
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Figure 6 
WI) 
i 
Formation of dihydrolysergyl peptides with modified LPS unable to 
release the corresponding lactam as end product. TLC separations in 
solvent system I of enzyme-bound peptide intermediates liberated from 
enzyme by alkaline treatment. Incubations contained: lane a, Mg ATP 
and 3H-dihydrolysergic acid; lane b, Mg ATP, 3H-dihydrolysergic acid 
and alanine; lane c, Mg ATP, 3H-DHLA, alanine and phenylalanine; 
lane d, Mg ATP, 3H-dihydrolysergic acid, alanine, phenylalanine and 
proline. The structure of the compound in band VI is shown. 
formation of intermediates in the absence of D-lysergic 
acid. Notably, proline was suggested as an alternative 
starter unit for peptide synthesis (‘tail growth mechanism’). 
When assaying LPS after incubation with ‘“C-proline and 
nonlabelled phenylalanine and alanine, however, radioac- 
tive proline was recovered exclusively from the enzyme, 
without any traces of covalently bound phenylalanyl- 
proline or alanyl-phenylalanyl-proline. This result is 
incompatible with chain growth starting at the carboxy-ter- 
minal proline (by the tail growth mechanism). These data 
also clearly demonstrate the role of o-lysergic acid for 
priming of peptide synthesis, because no proline peptides 
were seen in its absence. 
Autofluorograph of an SDS-polyacrylamide gel showing the 
distribution of bound dihydrolysergyl peptides covalently bound to 
LPS 1 and LPS 2. All incubation mixtures contained Mg ATP and 
3H-dihydrolysergic acid. Lane a, no addition; lane b, with addition of 
alanine; lane c, alanine and phenylalanine were added; lane d, alanine, 
phenylalanine and proline were added. 
Acyl transfer between LPS 1 and LPS 2, and the sequential 
condensations in peptide lactam formation 
LPS 2 harbours the peptide-synthetase domain for the 
activation and covalent binding of I)-lysergic acid (or 
dihydrolysergic acid), whereas LPS 1 contains the corre- 
sponding domains for the activation of alanine, phenyl- 
alanine and proline [13]. To determine the specific 
functions of the two enzyme subunits, both subunits 
were incubated with “H-dihydrolysergic acid and differ- 
ent combinations of alanine, phenylalanine and proline. 
The enzyme subunits were then separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE). Incubation with sH-dihydrolysergic acid alone 
exclusively labelled the 140kDa LPS 2 band, whereas 
LPS 1 was only faintly labelled (Fig. 6; lane a), which is 
most probably due to small amounts of alanine in the 
enzyme preparation. 
By contrast, the addition of nonlabelled alanine resulted in 
efficient labelling of both LPS 1 and LPS 2. This, together 
with the results shown in Figure 3, indicated that the 
radioactive label from dihydrolysergic acid moved from 
LPS 2 to LPS 1 in an alanine-dependent acyltransfer reac- 
tion (Fig. 6; lane b). Interestingly, labelling of LPS 1 with 
“H-dihydrolysergic acid-derived radioactivity increased 
when phenylalanine was added together with alanine 
(Fig. 6; lane c). Protein-bound label disappeared when 
proline was added, however, allowing completion of the 
reaction and release of the final product (Fig. 6; lane d). 
The amount of enzyme-bound “H-dihydrolysergic acid 
declined as the reaction progressed, as occurred in the 
experiment shown in Figure 3. 
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Figure 7 
1 Cluantitative analysis of the amounts of 
Amount of bound intermediates covalently bound-reaction intermediates and 
the liberated dihydrolysergyl peptide lactam. 
DHLA = dihydrolysergic acid. 
DHLA+Ala+Phe 
DHLA+Ah+Phe+Pro 
Substrates 
DHLA (I) Identity of bound intermediates 
i 
Distribution of the accumulating intermediates on LPS 
Figures 3 and 6 show that dihydrolysergic acid, dihydrol- 
ysergyl-alanine and dihydrolysergyl-alanyl-phenylalanine 
are present in different amounts on LPS 1 and LPS 2. 
The addition of alanine and phenylalanine to the reaction 
mixture caused a reduction in the dihydrolysergic acid 
that was bound to LPS 2, whereas the longest peptidyl 
intermediate that could be formed was always predomi- 
nant. This reflected the tendency to generate the end 
product. This trend culminated when proline was added, 
so that the free end product was formed almost exclu- 
sively (Fig. 7). The 4’-phosphopantetheine cofactors have 
been assigned earlier to function as both the primary 
acceptor groups of the activated amino acids and as the 
internal transport system which shifts the peptidyl inter- 
mediates under successive elongation steps from one 
domain to the next [24]. 
The uneven quantitative distribution of the various 
enzyme-bound dihydrolysergyl peptides was not the 
result of a chemical equilibrium between the peptide 
intermediates. Thioester formation was found to be irre- 
versible; exchange of “H-dihydrolysergic acid that was 
already bound to LPS 2 with nonlabelled dihydrolysergic 
acid was not detectable. Similarly, addition of aminobu- 
tyric acid did not result in any exchange of the alanine 
moiety in the dihydrolysergyl-alanine that was bound to 
LPS 1 (data not shown). Thus, the unequal distribution of 
reaction intermediates may reflect the factors that govern 
the programming of peptide chain growth, which must 
depend on the spatial positioning of the peptide syn- 
thetase domains and their 4’-phosphopantetheine arms, as 
well as on the structures and reactivities of interacting 
intermediates on the surface of the enzyme. The defined 
length of 4’-phosphopantetheine (-2Ow) and its motility 
define the region on the multienzyme complex where the 
peptidyl transfer reactions can take place. ‘I’his limits the 
amount of covalently bound intermediates to a restricted 
area. Thus an exactly ordered series of successi\c acyl 
transfer reactions leads to the end product. ‘I’he simulta- 
neous presence of different bulky Mysergyl pcptide 
intermediates in the reaction cavity may result in an 
impairment of accessibility of the sites that arc responsible 
for thioester formation. This suggests that the entry of I)- 
lysergic acid into the reaction cavity, which is absolutely 
necessary for priming peptide synthesis, is negatively reg- 
ulated by intermediates that are already present in the 
reaction space. Accordingly, under the conditions required 
for complete synthesis, I)-lysergic acid would enter into a 
new cycle only after the previous round of cyclopeptidc 
formation is finished and the product is released. This 
mechanism would be consistent with the obscrvcd bery 
low net concentrations of covalently bound intermediates 
(in particular I)-lysergic acid), and with the low turnover 
rates in the presence of all four substrates. 
Significance 
The data shown here give a detailed mechanistic view 
of the steps involved in the synthesis of the alkaloid 
cyclopeptides of the ergotamine, ergoxine and ergotox- 
ine group in Claviceps purpurea. The same principles 
probably also govern the biosynthesis of similar com- 
pounds in other fungi, some of which also cause disease 
when ingested. The mode1 deduced from these data is 
summarized in Figure 8. It differs significantly from 
previous models of cyclopeptide synthesis which impli- 
cate, for example, the incorporation of preformed di- 
ketopiperazines and D-Iysergyl peptides [ 111 into 
cyclopeptides under cell-free conditions. Also in con- 
trast to these models, our data clearly indicate a head- 
growth mechanism of D-Iysergyl peptide synthesis from 
the amino terminus to the carboxy terminus of the 
Figure 8 
Initiation 
Elongation step 1 
Elongation step 2 
: 
‘> 
HS 
Lactamization and product release 
Scheme of the events catalyzed by LPS in o-lysergyl peptide formation. 
The wavy line indicates the 20A 4’-phosphopantotheine arm. Instead 
of D-iySergiC acid, dihydrolysergic acid is shown. 
u-lysergyl peptide, as occurs in other nonribosomal 
peptide-synthetase systems. 
The irreversibility of thioester formation appears to 
dictate the direction of chain growth to form the end 
product, because no substrate exchange in peptidyl ester 
formation was observed. The uneven distribution of 
accumulating intermediates indicates constraints in the 
accessibility of sites involved in the priming step and 
hence in the formation of early intermediates by 
steric hindrance of the bulky peptidyl intermediates. The 
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absence of such covalently bound intermediates, under 
conditions favouring D-lysergyl peptide lactam synthesis 
revealed a strictly ordered sequence of reactions and indi- 
cates that priming activation (entry) of n-lysergic acid 
into the reaction cycle occurs only after the previous 
round of n-lysergyl peptide lactam synthesis is completed. 
This may describe a general rule in enzymatic peptide 
synthesis and may also explain the low turnover rates 
observed in these systems. We expect that future studies 
of u-lysergyl peptide synthetase at both enzymatic and 
genetic levels will provide further insights in the mecha- 
nisms of nonribosomal peptide synthesis systems. 
Materials and methods 
Strains and cultures 
Claviceps purpurea strain Dl producing ergotamine (200 to 
800 mg I-‘) with minor amounts of ergocryptine has been described 
previously [25]. Maintenance and culture conditions of the strain were 
as reported [25,261. 
Materials 
[9,1 O(n)-3HI-9,1 0-Dihydroergocryptine (17.5 Ci mMol-l) was from NEN. 
L-[Ui4CIPhenylalanine (448 mCi mMol-I), L-[U3H]alanine (45 Ci mMol-I) 
and L-[U-‘~C] proline (257 mCimMol-I) were from Amersham Interna- 
tional. [9,1 O(n)-3H]-9,1 0-Dihydrolysergic acid was prepared from 
[9,1 O(n)-3Hl-9,1 0-dihydroergocryptine as described previously [121. 
D-LySergiC acid and dihydrolysergic acid were kindly supplied by J.-J. San- 
glier (Novartis Pharma AG, Basel). Alanyl-phenylalanine was purchased 
from Bachem (Bubendorf, Switzerland). Hydrophobic matrix IF-Sorb used 
for solid phase extraction of D-lysergic acid and dihydrolysergyl peptides 
was obtained from IFB (D-061 20 Halle-Lettin, Germany). Silica thin layer 
chromatography (TLC) plates were from Merck (Darmstadt). All other 
chemicals were of the highest purity commercially available. 
Syntheses 
Dihydrolysergyl peptides were prepared from dihydrolysergic acid and 
amino acids (or dipeptides) using a general mixed anhydride procedure 
as described [271 with slight modifications: 30 bmoles DHLA were sus- 
pended in 2 ml dry tetrahydrofuran (THF) containing 30 umoles triethy- 
lamine and cooled down to -15°C. Ethylchloroformiate (30 bmoles) was 
added under intensive stirring. After 10 min, a solution of 30 pmoles 
amino acid (or dipeptide) in 60 ~1 1 N NaOH was added dropwise and 
was left to rise slowly to 0°C. After 60 min, the mixture was neutralized 
with 0.1 N HCI. Purification of products was by high performance liquid 
chromatography (HPLC) on Pharmacia RP18 (5 km, 250 x 4) columns 
using a 30 min gradient of O-30% acetonitrile in water (0.1% trifluo- 
roacetic acid; TFA) at a flow rate of 1 ml min-l. Yields were 40-60% for 
dihydrolysergyl monopeptides and 1 O-l 5% for dihydrolysergyl dipep- 
tides. Retention times in HPLC were: dihydrolysergyl-alanine, 14 min; 
dihydrolysergyl aminobutyric acid, 16 min; dihydrolysergyl valine, 19 min; 
dihydrolysergyl-alanyl-phenylalanine, 26 min. The identities of the prod- 
ucts were checked by acid and alkaline hydrolysis and subsequent TLC 
as described [131. 
Methods of analysis 
Enzyme-substrate complexes were isolated after 20 min incubation at 
28°C with radioactive substrates and precipitation with 7 O/o TCA (final 
concentration). The precipitated protein was collected by centrifugation 
and nonbound radioactivity was removed by washing twice with 2 ml 
7% TCA and twice with 2 ml ethanol. Pellets were dried in vacuum and 
dissolved in 250 (*I 0.1 N NaOH. The mixture was left for 15 min at room 
temperature. After neutralizing with 0.1 N HCI, the mixture was applied 
to a Pasteur pipette column containing IF-Sorb matrix. After washing 
the columns with several millilitres of water, dihydrolysergyl peptides 
were eluted with methanol, dried and finally applied to TLC plates. In 
the case of radioactive peptides not containing dihydrolysergic acid, the 
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precipitated protein samples were washed, dried, treated with per- 
formic acid, extracted with ethanol and finally applied to TLC plates. 
Plates were treated with EN3HANCE spray before exposing them to 
X-ray films. 
Radioactive materials from TLC were quantified by scraping radio- 
active bands off the plates, extracting them from silica gel in ethanol 
and counting in a scintillation counter. SDS-PAGE was performed 
as described [28]. Autofluorography of SDS gels was according to 
previously published procedures 1121. 
Enzyme assays 
All incubations were performed with freshly desalted enzyme fractions 
in buffers without DTE. Assays measuring o-lysergyl peptide lactam 
synthesis were as described [13]. Enzyme activity was measured by 
thioester formation using a filter-binding assay as described previously 
[29]. The assays leading to the formation of enzyme-bound dihydrolyser- 
gyl peptides contained in 100 )LI total volume 15 mM ATP, 20 mM MgCI, 
2 mM nonlabelled amino acid substrates (or 0.2 mM nonlabelled dihy- 
drolysergic acid), 0.25 t.LCi ‘4C-phenylalanine or 0.25 t&i 14C-proline or 
5 FCi 3H-alanine or lo6 dpm 3H-dihydrolysergic acid. Incubation time 
was 20 min at 28°C. 
Buffers and solvent systems 
Buffer A for the preparation of crude extracts of broken cells of C. pur- 
purea and buffer B used for gel filtration on Aca 34 were described pre- 
viously [131. TLC solvent system I : ethyl acetate : isopropanol : methanol : 
H,O (2:2:2:1, by vol). 
Enzyme purification 
Isolation of LPS was performed as described previously [131. The enzyme 
was desalted prior to incubation in DTE-free buffer B and immediately 
used for investigation. Partially deactivated enzyme was prepared by 
storage at < -25°C in DTE-free buffer B containing 50% glycerol. 
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